Library / Research areas / Growth hormone
Growth hormone
Peptides that act on the growth hormone axis, from approved medicines to research compounds.
These compounds are grouped by what they are studied for. Being studied for something is not the same as being proven to work, or safe. Compounds are listed from the strongest human evidence to the weakest.
Approved use · Regulator-approved for a specific indication
Mecasermin
Endocrine & Growth
70residues
7,649daltons
Evidence: Approved use
Somatropin
Endocrine & Growth
191residues
22,124daltons
Evidence: Approved use
Tesamorelin
Endocrine & Growth
44residues
5,135.9daltons
Evidence: Approved use
Controlled trials · Randomized trials with clinical endpoints
Early human · Small pharmacology or safety studies in people
CJC-1295
Endocrine & Growth
29residues
3,647.2daltons
Evidence: Early human
GHRP-2
Endocrine & Growth
6residues
817.98daltons
Evidence: Early human
GHRP-6
Endocrine & Growth
6residues
873.0daltons
Evidence: Early human
Hexarelin
Endocrine & Growth
6residues
887.0daltons
Evidence: Early human
Ipamorelin
Endocrine & Growth
5residues
711.9daltons
Evidence: Early human
Other research areas
Weight & metabolismEnergy & mitochondriaSleepRecovery & repairBrain & moodImmunitySkin & hairLongevity & agingSexual & reproductive healthHormones & boneHeart & blood
Educational reference only. Nothing here is medical advice, a treatment recommendation, or dosing or sourcing guidance.